E
Eivind Berge
Researcher at Oslo University Hospital
Publications - 175
Citations - 8630
Eivind Berge is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Stroke & Modified Rankin Scale. The author has an hindex of 36, co-authored 173 publications receiving 6709 citations. Previous affiliations of Eivind Berge include University of Oslo & University of Nottingham.
Papers
More filters
Journal ArticleDOI
Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life Results From the Scandinavian Candesartan Acute Stroke Trial
Astrid G. Hornslien,Else Charlotte Sandset,Philip M.W. Bath,Torgeir Bruun Wyller,Eivind Berge +4 more
TL;DR: Findings support the conclusion from the previous report that there is no indication for routine blood pressure–lowering treatment with candesartan in the acute phase of stroke and there were signs of harmful effects.
Journal ArticleDOI
Systematic review of organizational models for intra-arterial treatment of acute ischemic stroke:
TL;DR: There is insufficient evidence to recommend a particular, universal model for intra-arterial treatment of acute ischemic stroke, but different organizational models exist and the choice of model should depend on local factors and patient characteristics.
Journal ArticleDOI
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
Konark Malhotra,Aristeidis H. Katsanos,Nitin Goyal,Ashis Tayal,Henrik Gensicke,Panayiotis D. Mitsias,Gian Marco De Marchis,Eivind Berge,Anne W. Alexandrov,Andrei V. Alexandrov,Georgios Tsivgoulis +10 more
TL;DR: After adjustment for confounders in this pairwise meta-analysis, moderate to severe CKD is associated with increased risks of ICH and worse functional outcomes among patients with AIS treated with IVT.
Journal ArticleDOI
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment:
Hendrik Reinink,Jeroen C. de Jonge,Philip M.W. Bath,Diederik van de Beek,Eivind Berge,Saskia Borregaard,Alfonso Ciccone,László Csiba,Jacques Demotes,Diederik W.J. Dippel,Janika Kõrv,Iwona Kurkowska-Jastrzębska,Kennedy R. Lees,Malcolm R. Macleod,George Ntaios,Gary Randall,Götz Thomalla,H. Bart van der Worp +17 more
TL;DR: This trial will provide evidence for a simple, safe and generally available treatment strategy that may reduce the burden of death or disability in patients with stroke at very low costs.
Journal ArticleDOI
Understanding the relationship between costs and the modified Rankin Scale: A systematic review, multidisciplinary consensus and recommendations for future studies
Alastair Wilson,Philip M.W. Bath,Eivind Berge,Dominique A Cadilhac,Matthieu Cuche,Gary A. Ford,Rachael L. MacIsaac,Terence J. Quinn,Matthew Taylor,Matthew Walters,Claudia Wolff,Kennedy R. Lees +11 more
TL;DR: Few cost studies of stroke include information based on stroke recovery measured by individual modified Rankin Scale categories and the existing data are limited, so future studies are needed to reliably capture this information.